VITROMED is a leading global company that manufactures high-quality medical devices used during all stages in fertility treatment, from In Vitro Fertilization to embryo development for IVF clinics worldwide
Title Image

Biopsy

Biopsy

There are three main types of invasive preimplantation genetic testing (PGT):

  1. PGT-A (for aneuploidy): screens for chromosomal abnormalities like missing or extra chromosomes; often used in cases of recurrent miscarriage, advanced maternal age, or IVF failure.
  2. PGT-M (for monogenic disorders): detects specific mutations linked to inherited single-gene diseases; recommended for couples at known genetic risk.
  3. PGT-SR (for structural rearrangements): identifies chromosomal abnormalities such as translocations or inversions in parents with known rearrangements.

Non-invasive PGT methods are emerging, aiming to assess chromosomal abnormalities without embryo biopsy. These rely on analyzing cell-free DNA (cfDNA) from either blastocentesis or spent culture media though they still face technical challenges and are under validation for clinical use.